Safety Review Compromise

The administration tries to reduce interagency conflict by reframing the block as a temporary safety and readiness review rather than a permanent rejection of mRNA flu vaccines. This compromise would preserve political flexibility while avoiding a direct confrontation with the FDA’s approval process.

Each figure is the modeled move of the S&P 500 if the outcome occurs. For information only. Not investment advice.